BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22652628)

  • 1. Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway.
    Xu S; Evans H; Buckle C; De Veirman K; Hu J; Xu D; Menu E; De Becker A; Vande Broek I; Leleu X; Camp BV; Croucher P; Vanderkerken K; Van Riet I
    Leukemia; 2012 Dec; 26(12):2546-9. PubMed ID: 22652628
    [No Abstract]   [Full Text] [Related]  

  • 2. The bone marrow stromal compartment in multiple myeloma patients retains capability for osteogenic differentiation in vitro: defining the stromal defect in myeloma.
    Kassen D; Moore S; Percy L; Herledan G; Bounds D; Rodriguez-Justo M; Croucher P; Yong K
    Br J Haematol; 2014 Oct; 167(2):194-206. PubMed ID: 25079197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
    Berenstein R; Nogai A; Waechter M; Blau O; Kuehnel A; Schmidt-Hieber M; Kunitz A; Pezzutto A; Dörken B; Blau IW
    Mol Carcinog; 2016 Dec; 55(12):1927-1939. PubMed ID: 27023728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro expanded bone marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells can acquire CD34 expression and induce sarcoma formation in vivo.
    Xu S; De Becker A; De Raeve H; Van Camp B; Vanderkerken K; Van Riet I
    Biochem Biophys Res Commun; 2012 Aug; 424(3):391-7. PubMed ID: 22771324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carfilzomib promotes the osteogenic differentiation potential of mesenchymal stem cells derived from myeloma patients by inhibiting notch1 activity in vitro.
    Li Y; Li J; Zhuang W; Wang Q; Ge X; Zhang X; Chen P; Fu J; Li B
    Leuk Res; 2014 Aug; 38(8):970-6. PubMed ID: 24939218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
    Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
    Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dll1/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM-cell proliferation.
    Xu D; Hu J; Xu S; De Bruyne E; Menu E; Van Camp B; Vanderkerken K; Van Valckenborgh E
    Leukemia; 2012 Jun; 26(6):1402-5. PubMed ID: 22094583
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets.
    Giuliani N; Mangoni M; Rizzoli V
    Exp Hematol; 2009 Aug; 37(8):879-86. PubMed ID: 19446662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutual interaction between myeloma cells and bone marrow microenvironment].
    Abe M
    Rinsho Ketsueki; 2009 Jun; 50(6):453-60. PubMed ID: 19571504
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
    Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
    J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-9 promotes differentiation of mouse bone mesenchymal stem cells into neurons by Notch signaling.
    Jing L; Jia Y; Lu J; Han R; Li J; Wang S; Peng T; Jia Y
    Neuroreport; 2011 Mar; 22(5):206-11. PubMed ID: 21346646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.
    García-Bernal D; Redondo-Muñoz J; Dios-Esponera A; Chèvre R; Bailón E; Garayoa M; Arellano-Sánchez N; Gutierrez NC; Hidalgo A; García-Pardo A; Teixidó J
    J Pathol; 2013 Jan; 229(1):36-48. PubMed ID: 22711564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between a murine myeloma cell line and bone marrow stromal cells.
    Bradley TR; Kriegler AB; Verschoor SM; Tzelepis SM; Cooper IA
    Exp Hematol; 1996 Feb; 24(2):307-9. PubMed ID: 8641357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward development of a novel NOD/SCID-based in vivo strategy to model multiple myeloma pathogenesis.
    Bueno C; Lopes LF; Greaves M; Menendez P
    Exp Hematol; 2007 Oct; 35(10):1477-8. PubMed ID: 17681665
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
    Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
    Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 stimulates hematopoiesis in murine osteogenic stroma.
    Van Vlasselaer P; Falla N; Van Den Heuvel R; Dasch J; de Waal Malefijt R
    Clin Orthop Relat Res; 1995 Apr; (313):103-14. PubMed ID: 7641467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled extracellular macromolecular matrices and their different osteogenic potential with preosteoblasts and rat bone marrow mesenchymal stromal cells.
    Bae SE; Bhang SH; Kim BS; Park K
    Biomacromolecules; 2012 Sep; 13(9):2811-20. PubMed ID: 22813212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of notch signaling in human embryonic stem cell-derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivo.
    Borghese L; Dolezalova D; Opitz T; Haupt S; Leinhaas A; Steinfarz B; Koch P; Edenhofer F; Hampl A; Brüstle O
    Stem Cells; 2010 May; 28(5):955-64. PubMed ID: 20235098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serine protease HTRA1 positively regulates osteogenesis of human bone marrow-derived mesenchymal stem cells and mineralization of differentiating bone-forming cells through the modulation of extracellular matrix protein.
    Tiaden AN; Breiden M; Mirsaidi A; Weber FA; Bahrenberg G; Glanz S; Cinelli P; Ehrmann M; Richards PJ
    Stem Cells; 2012 Oct; 30(10):2271-82. PubMed ID: 22865667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche.
    Tsukamoto S; Løvendorf MB; Park J; Salem KZ; Reagan MR; Manier S; Zavidij O; Rahmat M; Huynh D; Takagi S; Kawano Y; Kokubun K; Thrue CA; Nagano K; Petri A; Roccaro AM; Capelletti M; Baron R; Kauppinen S; Ghobrial IM
    Leukemia; 2018 Aug; 32(8):1739-1750. PubMed ID: 29925904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.